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The Gbg Sensitivity of a PI3K Is Dependent
upon a Tightly Associated Adaptor, p101
L. R. Stephens,* A. Eguinoa,* 3-phosphorylating (Whitman et al., 1988) at least one,
but often all, of the cellular phosphoinositides: PtdIns,H. Erdjument-Bromage,² M. Lui,² F. Cooke,*
J. Coadwell,* A. S. Smrcka,³ M. Thelen,§ PtdIns4P, and PtdIns(4,5)P2 (Auger et al., 1989). The
first and best characterized subfamily is comprised ofK. Cadwallader,‖ P. Tempst,² and P. T. Hawkins*
*The Inositide Laboratory heterodimers containing a regulatory subunit (see be-
low) and a 110 kDa catalytic subunit (including 110a andDepartment of Signalling
The Babraham Institute 110b) (Hiles et al., 1992; Hu et al., 1993). Both p110a and
p110b are covalently modified and potently inhibited byCambridge CB2 4AT
United Kingdom the fungal metabolite wortmannin (Acaro and Wymann
1993; Yano et al., 1993) and can phosphorylate all three²Molecular Biology Program
Memorial Sloan-Kettering Cancer Center lipid substrates in vitro. However, they appear to be
PtdIns(4,5)P2-selective, and hence PtdIns(3,4,5)P3-pro-New York, New York 10021
³Pharmacology and Physiology Department ducing, in vivo (Stephens et al.,1991). The knownregula-
tory adaptors (p55a, p55 PIK, p85a, and p85b; Otsu etUniversity of Rochester
Rochester, New York 14642 al., 1991; Pons et al., 1995; Inukai et al., 1996) contain a
§Theodor-Kocher-Institute large collection of protein±protein interaction domains,
Der UniversitaÈ t Bern the best studied of which are protein tyrosine phos-
P.O. Box (Freiestrasse 1) phate±binding SH2 domains (Songyang et al., 1993). The
CH-3000 Bern 9 binding of tyrosine phosphates to the SH2 domains of
Switzerland PI3K directly activates the PI3K catalytic subunit (al-
‖Onyx Pharmaceuticals though this effect is relatively small in vitro; Carpenter
3031 Research Drive et al., 1993) and translocates the cytosolic PI3K to a
Richmond, California 94806 source of its phospholipid substrate, leading to an in-
crease in PtdIns(3,4,5)P3 production. Clearly, this family
of PI3Ks is structurally adapted to function as dedicated
signal transducers downstream of receptor-regulatedSummary
tyrosine kinases, much like the way the g family of PI-
PLCs is regulated by receptor-sensitive tyrosine kinasesTwo highly similar, PtdIns(4,5)P2-selective, Gbg-acti-
(Lee and Rhee, 1995). These p85/p110-type PI3Ks havevated PI3Ks were purified from pig neutrophil cytosol.
been classified as type I PI3Ks. Type II enzymes containBoth were heterodimers, were composed of a 101 kDa
a C-terminal C2 domain and prefer PtdIns and/orprotein and either a 120 kDa or a 117 kDa catalytic
PtdIns4P as substrates. Type IIIs, which are relatives ofsubunit, and were activated greater than 100-fold by
the VPS34p PI3K in yeast, associate with a protein ki-Gbgs. Peptide sequence±based oligonucleotide probes
nase and only phosphorylate PtdIns (MacDougall et al.,were used to clone cDNAs for the p120 and p101 spe-
1995; Zvelebil et al., 1996).cies. The cDNA of p120 is highly related to p110g,
while the cDNA of p101 is not substantially related The accumulation of PtdIns(3,4,5)P3 that occurs in re-
to anything in current databases. The proteins were sponse to activation of heterotrimeric G protein±linked
expressed in and purified from insect and mammalian receptors, particularly ATP receptors on U937 cells (Ste-
cells. They bound tightly to one another, both in vivo phens et al., 1994), is unlikely to involve a p85/p110 PI3K
and in vitro, and in so doing, p101 amplified the effect (although some work suggests that FMLP receptors on
of Gbgs on the PI3K activity of p120 from less than fully primed neutrophils may be able to activate a p85/
2-fold to greater than 100-fold. p110 PI3K after long 0.5 min periods of stimulation;
Stephens et al., 1993; Ptasznik et al., 1996). Recent evi-
dence has identified a chromatographically distinct formIntroduction
of wortmannin-sensitive, PtdIns(4,5)P2-selective PI3K
present in U937 cells and neutrophils. This form of PI3KA variety of extracellular transmitters, which utilize re-
can be specifically and substantially activated by heter-ceptors that activate heterotrimeric GTPases or protein
otrimeric GTPase bg subunits (Gbgs, but not Ga-GTPtyrosine kinases, can stimulate accumulation of phos-
subunits) and possesses a native, relative molecularphatidylinositol (3,4,5)-trisphosphate [PtdIns(3,4,5)P3] in
mass of about 220 kDa (Stephens et al., 1994). A similartheir target cells (Traynor-Kaplan et al., 1988; Auger et
PI3K activity has also been described in an osteosar-al., 1989). This event is now considered an important
coma cell line (Morris et al., 1995). Stoyanov et al. (1995)intracellular signal upstream of a variety of responses
have recently published the cloning and expression ofsuch as insulin-stimulated glucose uptake, ruffling, su-
a wortmannin-sensitive, PtdIns(4,5)P2-selective PI3Kperoxide production, activation of p70S6K, and activation
from a human bone marrow cDNA library (p110g). It isof AKT/PKB, among others (Chung et al., 1994; Hara et
clearly distinct from p110a and p110b, particularly in itsal., 1994; Thelen et al., 1994; WennstroÈ m et al., 1994;
lack of an NH2-terminus-binding domain for a memberFranke et al., 1995). PtdIns(3,4,5)P3 is known to be a
of the p85 adaptor family, and has been classified as apotential product of phosphoinositide 3-kinases (PI3Ks).
PI3Ks form a large family of enzymes capable of type IB PI3K (p85/p110-type PI3Ks becoming IA PI3Ks).
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that both activities comigrated with two proteins: PI3K-A
with proteins of 117 kDa (which specifically bound [3H]-
17-hydroxy-wortmannin and were therefore assumed to
be catalytic) and 101 kDa, and PI3K-B with proteins of
120 kDa (which also bound [3H]-17-hydroxy-wortman-
nin) and 101 kDa, hence indicating that the PI3K ac-
tivities were p117/p101 and p120/p101 heterodimers
in their native state. In their final forms, PI3K-A and
PI3K-B had been purified approximately 180,000-fold
and 370,000-fold from neutrophil lysateswith 5.5% over-
all recovery of activity. Purified preparations of PI3K-A
and PI3K-B were indistinguishable on the basis of their
lipid kinase activities. They were both found to be: acti-
vated over 100-fold by Gbg subunits in a Ga-GDP-sensi-
tive fashion; completely inhibited by 100 nM wortmannin
(with 5 mM ATP in the assays); insensitive, either in the
presence or absence of Gbgs, to tyrosine-phosphory-
lated peptides (which activate p85/p110 family PI3Ks
5-fold); insensitive toaluminum fluoride±activated, GDP-
bound Gai subunits; and capable of phosphorylating
PtdIns, PtdIns4P, and PtdIns(4,5)P2. However, they dis-
played the lowest apparent KM for PtdIns(4,5)P2 (8 mM
and 10 mM for PI3K-A and PI3K-B, respectively), utilizing
the g-phosphate of ATP as the phosphate donor (seeFigure 1. Characterization of PI3K-A and PI3K-B
Figure 1).
(Upper) Aliquots (4%, v/v) of each of the fractions across the peaks
of PI3K activity eluting from the final purification steps for both
PI3K-A and PI3K-B were incubated with [3H]-17-hydroxy-wortman-
Peptide Sequencing of Gbg-Activated PI3K-Anin, resolved by SDS±PAGE (6% acrylamide), and stained with col-
loidal Coomassie G250 (see right gel; note that photographs of the and PI3K-B and Cloning of p120 and p101
same, identically aligned gel are shown). PI3K activity peaked in PI3K-A and PI3K-B, purified from the equivalent of 45
fraction 9 for PI3K-A and in fraction 8 for PI3K-B. Protein-bound g of cytosolic protein, were Western blotted onto nitro-
[3H]-17-hydroxy-wortmannin was localized by fluorography (see left cellulose and stained with Ponceau S. The bands corre-
gel; note that in the image shown, the peak fractions were allowed
sponding to all four subunits were excised, treated withto overexpose the film to demonstrate the specificity of binding).
trypsin, and processed for internal amino acid sequenceThe position to which a set of molecular size standards migrated
is marked. analysis. Peptide sequence data resolved several issues
(Lower) The effects of various reagents on the lipid kinase activity regarding the relationships between these proteins. The
of PI3K-B. Assays were conducted with PtdIns(4,5)P2 as a substrate p101s derived from both PI3K-A and PI3K-B were identi-
as described below, with or without 30 mM doubly tyrosine-phos- cal, and furthermore, a relatively common allelic variant
phorylated peptide (PY peptide), 100 nM wortmannin, 1 mM Gai (with
was identified at 483 in the ORF (marked in Figure 2).or without 10 mM sodium fluoride and 30 mM aluminum chloride),
p117 and p120 displayed virtually identical tryptic HPLCand 0.5 mM Gbgs.
profiles, and all apparently common peptides that were
sequenced from both species were identical, with theIt was speculated that p110g constituted the PI3K activ-
exception of an NH2-T (NH2-terminal)-blocked peptideity downstream of heterotrimeric GTPase-linked recep-
from p117 (see below). A degenerate oligonucleotidetors, although this hypothesis clearly left several unre-
probe, based on the sequence of a peptide from p120,solved questions regarding earlier work (e.g., the
was used to screen an oligo(dT)-primed pig neutrophilapparent native, relative molecular mass).
cDNA library. Two clones defined a full-length ORF en-This paper describes experiments that were aimed at
coding all of the p117/p120 tryptic peptides (see Figurecharacterizing the Gbg-sensitive PI3K activity we pre-
2). Of two potential start methionines, the 59 one wasviously detected in myeloid-derived cells.
identified as active on the basis of the precise match
between the measured mass of an NH2-T-blocked,Results
p120-derived peptide and the theoretical masses of
NH2-T tryptic peptides that would be derived as a resultPurification and Characterization
of initiating translation at the alternative methionines.of Gbg-Activated PI3K Activities
This was confirmed by postsource decay (PSD) massAnalysis of pig neutrophil cytosol by ion-exchange chro-
spectrometric sequencing using a MALDI-reflectronmatography showed that it contained a Gbg-activated
TOF mass analyzer (data not shown). As such, p120 hasPI3K activity of similar properties to one already de-
a theoretical size of 126 KDa. The mass of a blocked,scribed in U937 cells. The Gbg-activated PI3K activity
and therefore presumably N-terminally located, trypticwas purified further and split into two peaks that both
peptide from p117 could not be satisfactorily matcheddisplayed native, relative molecular masses of 220 kDa
with any sequence (assuming acetylation of the first(we intend to publish the details of this purification sepa-
residue) in the N-terminal region of the p120 ORF. Puta-rately). Once essentially pure, as assessed by Coomas-
sie-stained SDS±PAGE gels (see Figure 1), it was clear tive sequence differences between p117 and p120, likely
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defining p120 were used to search databases for similar
structures. Similarities with all previously cloned PI3Ks
were identified. The sequence was nearly identical to
p110g, allowing for species differences (Stoyanov et
al., 1995). The only significant discrepancy between our
sequence and that of p110g is found in the extreme
COOH-T (dashed underlining in Figure 2). During a re-
cent, independent cross-check of this sequence, Stoya-
nov et al. identified a reading error that had resulted in
a frameshift and predicted a premature stop codon.
Their corrected sequence now agrees with ours (R. Wet-
zker, personal communication).
A full-length clone defining p101 has not been iso-
lated, but by utilizing several overlapping fragments de-
rived from both oligo(dT)- and random-primed, pig neu-
trophil cDNA libraries, a full-length ORF encoding all
of the peptide sequence derived from p101 has been
defined. A p101-derived, NH2-T-blocked peptide was
identified. Its mass was precisely equivalent to that pre-
dicted for an NH2-T-acetylated version of the first 12
residues defined by the predicted start in the ORF de-
scribed and a tryptic cleavage site (Arg) at position 12.
The predicted relative molecular mass of p101 is 97 kDa
(see Figure 2). The protein and DNA sequence databases
were searched for similar structures or substructures;
none were found.
Analysis of Northern blots of poly(A)-selected pig neu-
trophil RNA with probesspecific for p120 and p101 (both
NH2-T-derived) revealed the presence of very low abun-
dance messages of the expected sizes (3.8 and 4.5 kb,
respectively; data not shown).
Expression of p120 and p101 in Insect Cells
Recombinant, clonal baculoviruses (RBV) harboring ei-
ther an NH2-T, 63 HIS±tagged p120 cDNA (pAcHLT
p120) or an NH2-T, (EE)-tagged p101 cDNA (pAcO-G1
p101) were prepared and used to drive production of
the above proteins in insect cells (Sf9). Single-step puri-
fications utilizing the tags yielded both proteins at
greater than 90% purity. Their apparent sizes matched
expectation, and both were recognized in Western blots
by specific, COOH-T-directed and internal sequence±
directed antipeptide rabbit polyclonal sera, indicating
their authenticity (data not shown).
p120 bound tightly, in 1:1 molar stoichiometry, to p101
both in vitro, when both proteins had been indepen-
dently purified and mixed (see Figure 3), and in vivo,
when Sf9 cells were coinfected with both forms of RBV
and proteins were purified via the p101 tag (data not
shown).
Free, purified p120 was a PtdIns(4,5)P2-selective,Figure 2. The Amino Acid Sequences of p120 and p101
wortmannin-sensitive PI3K. Gbgs had a small, bimodalThe nucleotide sequences of cDNAs encoding p120 and p101 are
effect on free p120 PI3K activity. An equimolar mixtureshown. The deduced amino acid sequences of p101 and p120 are
of Gas (final total concentration of 2 mM of Gas o, i1, i2,shown in single letter code. The sequences of peptides obtained
from tryptic digests of purified p120 and p101 are underlined in and i3 bound to GDP) in the presence of aluminum fluo-
bold. Two tryptic peptides were obtained from p101 that differed ride had no significant effect on free p120 PI3K activity.
only by Ser/Gly in their second residues (indicated by an asterisk), This preparation of Gas, when added in a 1.5-fold molar
suggesting allelic variation in sequence.
excess, could completely inhibit the effects of Gbgs on
PI3K. Tyrosine-phosphorylated peptides able to acti-
vate p85/p110 PI3K family members also had no detect-to reside at the N terminus, must therefore be recog-
nized. However, a cDNA with an ORF encoding p117 able effect on p120 PI3K activity (see Figure 5).
When bound to p101 (either in vivo or in vitro), thehas not been isolated. The protein and DNA sequences
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108
Figure 3. Immobilized p101 Binds Purified
p120
Assays (A±F) were constructed. They con-
tained 0.27 nmols (EE)-p101 (immobilized on
a-[EE]-beads) or an equivalent fraction puri-
fied from Sf9 cells infected with wild-type BV
(p101C), and 2.7 nmol of p120 or an equiva-
lent fraction purified from Sf9 cells infected
with wild-type BV (p120C). After 2 hr of mix-
ing, the beads were washed and specifically
bound proteins were eluted with (EE)-pep-
tide. Each fraction (2.45, v/v) was resolved by
SDS±PAGE (8% acrylamide) and stained with
Coomassie R250 (see gel at left). Each frac-
tion (0.2%, v/v) was assayed for PI3K activity
with and without Gbg subunits (1 mM final
concentrations). The components added to
each assay are defined beneath the graph at
right.
PI3K activity of p120 could be activated greater than was absent in controls using either an irrelevant mono-
clonal antibody for the immunoprecipitation or a cDNA100-fold by Gbgs. Tyrosine-phosphorylated peptides
and Ga-GDP/aluminum fluoride had no effect on Gbg- encoding an (EE)-tagged irrelevant protein (see Figure
activated, or basal, p101/p120 PI3K activity. In the ab-
sence of Gbgs, the specific activity of p120 in a p101/
p120 complex is lower than the specific activity of free
p120 (24% 6 5%, n 5 6) but is increased greater than
50-fold in their presence (see Figures 4 and 5). The
specific activities of recombinant p101/p120 hetero-
dimer toward PtdIns, PtdIns4P, or PtdIns(4,5)P2 was 0.8,
0.6, or 2 fmol of product/mi/pmol of PI3K (with 500 mM,
50 mM, and 50 mM lipid concentrations, respectively,
and 100 mM ATP) and 20, 60, and 300 fmol product/
min/pmol of PI3K, respectively, in the presence of 0.5
mM Gbgs (other conditions as defined in the Experimen-
tal Procedures). Sf9-derived p101/p120 had a 2-fold
higher specific activity than pig neutrophil±derived
PI3K-B. This suggests that the bulk of the recombinant
enzyme is correctly folded and processed.
To assess if Gbgs could bind to (EE)-p101 and/or (EE)-
p120, the latter proteins were purified from Sf9 cells,
incubated with bovine brain±derived Gbgs, and rapidly
washed. Bound proteins were then analyzed by SDS±
PAGE. Under a variety of conditions, 5-fold more Gbgs
were recovered, per mole input protein, specifically (i.e.,
above control) associated with (EE)-p101 than (EE)- Figure 4. p101 Confers p120 Sensitivity to Gbg Subunits
p120. Furthermore, binding was completely inhibited by (Upper) Assays containing 12 nM purified p120 (final concentration)
preincubating the Gbgs with a 2-fold molar excess of alone, or as p101/p120 heterodimers that had been formed by either
reconstitution from purified components in vitro or by coinfectionGDP-bound Gai (Figure 6).
of Sf9 cells with RBV-pAcHLT p120 and RBV-pAcO-Gl p101 and
purification of the heterodimer via the (EE)-tag on p101. The different
preparations were assayed in the presence of a range of concentra-Expression of p101 and p120 in Mammalian Cells
tions of Gbgs. Data are means of duplicates; the ranges fell withinA family of mammalian expression vectors with NH2-T the symbols.
epitope-tagged forms (either [myc] or [EE]) of p101 and (Lower) The bar graph shows data from experiments similar to those
p120 were constructed. When transiently expressed in above, except that the axis scales are set to indicate the dose-
dependent, bimodal effects of Gbg on free p120 in these prepara-U937 cells, (EE)-p101 and (EE)-p120 could be specifi-
tions (conditions: (1), no Gbgs; (2), 0.035 mm; (3), 0.1 mM; (4), 0.35cally immunoprecipitated from 35S-methionine-labeled
mm; (5), 1.0 mM Gbgs; all final concentrations), the linearity of thecells in approximately equal amounts (allowing for
assays containing free p120, under these conditions, and the smalltheir relative content of methionines; 8:25, respectively;
but significant inhibition of p120 PI3K activity in the p101/p120 het-
data not shown). Stringently washed a-(EE)-p101 im- erodimers, in the absence of Gbg. The assays in the upper graph
munoprecipitates contained a wortmannin-sensitive, contained 5-fold more [g32P]-ATP. The data shown are means of
duplicates (the average range of these means was 4.4%).PtdIns(4,5)P2-selective, Gbg-sensitive PI3K activity that
Gbg-Regulated PI3Ks
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Figure 5. Pharmacological and Regulatory
Properties of Free p120 and p101/p120 PI3Ks
Assays contained either 20 nM p101/p120 or
100 nM p120 alone (final concentrations) that
were incubated with various reagents (10 mM
NaF and 30 mM AlCl3 [A/F], 1 mM Gbgs, 2 mM
Ga-GDP, 100 nM wortmannin [W], or 50 mM
tyrosine-phosphorylated peptide [PY] for a
total of 15 min (at 08C) prior to starting the
assays by adding [g32P]-ATP. [32P] incorpo-
rated into [32P]-PtdIns(3,4,5)P3 was quantified.
The data shown are means (n 5 2); the aver-
age range of these means was 6.4%.
7). The activation by Gbgs was blocked by preincubation Ga-GDP/aluminum fluoride (data not shown). Cotrans-
fection of (myc)-p120 with (EE)-p101 did not increasewith a 2-fold molar excess of Ga-GDP. The PI3K activity
the PI3K activity specifically recovered in a-(EE) immu-in these p101 immunoprecipitates was insensitive to
noprecipitates. Indeed, it decreased, probably because
the expression of 35S-methionine-labeled (EE)-p101 was
lower in the presence of (myc)-p120 expression vectors
(data not shown). In contrast, in cells transfected with
(EE)-p120, a-(EE) immunoprecipitates contained barely
detectable PI3K activity either in the presence or ab-
sence of Gbgs. Cotransfection with (myc)-p101 resulted
in a substantial increase in the Gbg-stimulated PI3K
activity that could be recovered, despite a fall in the
expression of (EE)-p120 (as judged by 35S-methionine
labeling) (see Figure 7). We interpret these data to indi-
cate that U937 cells (human) contain an endogenous
PI3K catalytic subunit that can bind to a transiently ex-
pressed p101 (pig), and because all of the p120 present
in these immunoprecipitates is bound to p101, this cata-
lytic subunit displays substantial regulation by Gbgs. In
a-(EE) immunoprecipitates from (EE)-p120-transfected
cells, much of the p120 is unassociated with p101 and
hence relatively inactive even in the presence of Gbgs;
however, cotransfection with (myc)-p101 amplifies the
Gbg-activated PI3K activity in (EE)-p120 immunoprecip-
itates. An alternative explanation for these data could
be that the p120 is ªdenaturedº unless expressed in theFigure 6. Gbgs Bind to p101
presence of p101 (although this p120 is soluble and
Gbgs were incubated with a-(EE)-beads (lanes 1 and 6) or with
capable of being immunoprecipitated). However, wesimilar beads already bound to nonspecific Sf9-derived proteins
consider this unlikely in view of the data obtained in(lanes 2 and 7), (EE)-p101 (lanes 3, 8, 10, and 11), or (EE)-p120 (lanes
experiments reconstituting independently-purified, Sf9-4 and 9). Gbgs in some assays were preincubated with a 2-fold
molar excess of either boiled (lane 11) or unboiled (lane 10) Ga i- derived proteins.
GDP. The beads were further washed in the binding buffer, then To test whether the p101/p120 PI3K could be acti-
eluted with SDS sample buffer. The bound proteins were resolved by vated by Gbgs and produce PtdIns(3,4,5)P3 in vivo, weSDS±PAGE (12% acrylamide), detected by staining with Coomassie
transiently expressed various combinations of (myc)-g2,R250, and quantitated by densiometric scanning. The figure shows
(EE)-b1, (myc)-p101, and (myc)-p120 in cos-7 cells anda photograph of a stained gel from a typical experiment and a bar
measured their effects on the levels of [32P]-phospho-graph with data accumulatedfrom 5 independent experiments. Lane
numbering refers to conditions defined in the bar graph, except that inositides in cells 48 hr after transfection. p120 only
in lane 5, the (EE)-120-loaded beads had been eluted with (EE)- produced significant increases in PtdIns(3,4,5)P3 and
peptide prior to assay; in lane 11, the (EE)-p101 preparation was PtdIns(3,4)P2 in a b1g2-dependent fashion in the pres-incubated with boiled ai-GDP and Gbgs; and in lane 12, the (EE)- ence of p101. This pattern of results could not be ex-p101 preparation was loaded with an aliquot of Gbgs equivalent to
plained by changes in the relative expression of the80% of the Gbgs that would be recovered from the assays if all
different cDNAs when introduced in combinations (seebound. The data shown are means 6 SE (n 5 3±10) (except those
including Gai-GDP proteins, which are means of duplicates). Figure 8).
Cell
110
Figure 7. p101 Can Associate with a Gbg-Stimulated PI3K Activity
Figure 8. Regulation of p101/p120 by Gbgs In Vivoin U937 Cells
(Upper) Cos-7 cells were transfected with mammalian expression(Upper) U937 cells were transiently transfected with mammalian
vectors as indicated. After 48 hr, cells from each transfection wereexpression vectors encoding (EE)-p101 (lanes 1±4) or two other,
serum starved. They were then lysed, Western blotted, probed withirrelevant, (EE)-tagged proteins (lanes 5±8). Lysates were prepared,
an a-(myc) monoclonal antibody to quantitate the expression of theprecleared, and immunoprecipitated with protein G±Sepharose co-
various (myc)-tagged proteins, and labeled with [32P]-Pi. Results arevalently cross-linked to either a-(EE) (lanes 1,2, and 5±8) or a-(myc)
given relative to the expression obtained in the presence of all four(lanes 3 and 4) monoclonal antibodies. After stringent washing, the
key vectors (note that the absolute levels of [myc]-p120 and [myc]-beads were assayed for PtdIns(4,5)P2-directed PI3K activity in the
p101 were very similar and about 10-fold greater than that ofpresence and absence of Gbgs (1 mM final concentration), as indi-
[myc]-[2]). After 90 min, lipids were extracted and deacylated, andcated. The assays were then terminated, and their lipids were ex-
water-soluble head groups were resolved by anion-exchange HPLCtracted, deacylated, and resolved on PEI-TLC plates. An autoradio-
and quantitated by liquid scintillation counting. Data shown aregram of the TLC plate is shown.
means 6 ranges (n 5 2). Data for [32P]-PtdIns(3,4,5)P3 are above the(Lower) U937 cells were transiently transfected with a total of 40 mg
irrelevant DNA control (972 6 41 dpm). The pattern of changes in theof DNA as indicated, then lysed, precleared, and immunoprecipi-
levels of [32P]-PtdIns(3,4)P2 was very similar to that of PtdIns(3,4,5)P2,tated with protein G±Sepharose covalently cross-linked to a-(EE)
while the [32P]-PtdIns3P levels did not change significantly.monoclonal antibody. The resulting immunoprecipitates were
(Lower) Cos-7 cells were treated as described above, except thatwashed, and PI3K activity was assayed with or without Gbgs (1 mM,
some were also transfected with HA-tagged PKB or kinase-deadfinal concentration). The PI3K activity detected in immunoprecipi-
PKB. After serum starvation, cells (32P-Pi-labeled or not) were stimu-tates from cells transfected with irrelevant (EE)-tagged protein, ei-
lated with LPA and either lysed for assay of HA-immunoprecipitatedther with or without Gbgs, was subtracted from the data shown
PKB activity or quenched with 1 M HCl; 32P-labeled 3-phosphory-(these were means of 1896 dpm and 2862 dpm in the absence and
lated lipids were quantitated as described. Parallel data describingpresence of Gbgs, respectively). Data shown are means (n 5 2±3);
the LPA-stimulated increase in specific HA immunoprecipitate±the average range on these means was 5.1%. Parallel transfections
associated PKB activity in the presence or absence of p101 andlabeled with [35S]-methionine showed that the amount of [35S]-p101
p120 are also shown (means 6 range, n 5 2). In this case, theand [35S]-p120 in the immunoprecipitates fell by 40% when they
LPA-stimulated increase in [32P]-PtdIns(3,4)P2 and the levels of [32P]-were cotransfected (data not shown).
PtdIns(4,5)P2 in the same samples are shown (means 6 range, n 5
2) in the presence or absence of p101 and p120. An identical pattern
of results was seen with [32P]-PtdIns(3,4,5)P3. There were no signifi-
To address the issue of whether p101/p120 PI3K can cant changes in the levels of [32P]-PtdIns3P.
be regulated by cell surface receptors and in turn regu-
late intracellular signaling pathways, we utilized the
LPA receptors present on cos-7 cells that are known PtdIns(3,4,5)P3 and PtdIns(3,4)P2 accumulation (Figure
8). Cotransfection of mammalian expression vectors en-to activate pertussis toxin±sensitive (i.e., Gai-linked)
cellular responses. Transient transfection of p101 and coding p101 and p120 with HA-tagged PKB showed
that this enhanced LPA-stimulated accumulation ofp120 cDNAs amplified the ability of LPA to stimulate
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Na2HPO4, 1.46 mM KH2PO4, and 5 mM MgCl2 (at 2.8 3 107 cells/ml),PtdIns(3,4)P2 and PtdIns(3,4,5)P3 was paralleled by a
mixed with 40 mg of total DNA (in 50 ml of EM and made up to 40substantial increase in the ability of LPA to stimulate
mg with control DNA), and transferred to a cuvette (0.4 cm gap;activation of PKB in vivo.
BioRad). The cells were electroporated (1 pulse at 280 V and 960
mF), then diluted into 35 ml of RPMI, 10% HIFBS, supplementedwith
penicillin and streptomycin, TPA, and ZnCl2 (final concentrations ofDiscussion
5 3 1028 M and 200 mM, respectively). If the cells were to be labeled
with 35S-methionine (translabel; ICN), then the RPMI used after theIt has been proposed that a novel p46/p110 heterodimer
electroporation was methionine- and leucine-free and contained 2
underlies Gbg-sensitive PI3K activity (Kurosu et al., mM NaHCO3, 25 mM HEPES, 10% dialyzed HIFBS, and 20 mCi/ml
1995). This proposal is based of the observation that a 35S-methionine (plus TPA and ZnCl2, as above). After 12 hr (either
crude preparation of a 150 kDa (native), Gbg-sensitive with or without 35S) di-isopropylfluorophosphate (1 mM final concen-
tration) was added, then the cells were washed once with PBSPI3K activity contained both a 46 kDa protein that cross-
and lysed for immunoprecipitation with a-(EE) monoclonal antibodyreacted with an a-p85a antibody and a 100 kDa wort-
covalently attached to protein G±Sepharose [a-(EE) beads] and sub-mannin binding protein. Similarly, a Gbg-sensitive PI3K
sequent PI3K assay (see below), or SDS±PAGE and autoradiogra-
activity that is apparently recognizedby ap85 antibodies phy. Exponentially growing cos-7 cells were trypsinized, washed
has been described in platelets (Thomason et al., 1994). twice in PBS, andresuspended in EM (2 3 107/ml)mixed with circular
None of these reports has yet led to a complete charac- plasmid DNA (40 mg total per cuvette, made up of combinations of
10 mg of EXV-(EE)-b1, 10 mg of EXV-(myc)-g2, 10 mg of pCMV-(myc)-terization of the enzyme responsible, but it remains pos-
p120, 10 mg of pCMV-(myc)-p101, or 10±40 mg of an irrelevant mam-sible that there are several forms of Gbg-sensitive PI3K
malian expression vector (0.5 ml final volume). The cells were elec-activity.
troporated (250 V, 960 mF) and aliquoted into 6 cm dishes (the
Our data indicate that expression of p101 and p120 equivalent of 5 from each cuvette). After 48 hr, dishes were washed
(p110g; we consider p110g to be the most appropri- into HEPES-buffered DMEM containing 1 mM NaHCO3 and 0.2%
ate name for the catalytic subunit we have described) fatty acid±free BSA. After another 10 hr, two replicate dishes were
harvested for Western blotting with a-(myc) monoclonal antibodyin mammalian cells can substantially amplify the ability
as the 18 detection reagent. The remaining dishes were washed intoof both transiently transfected Gbgs and endoge-
similar but Pi-free medium, then incubated for another 90 min atnous receptors capable of activating Gai to stimulate 378C with 300 mCi [32P]-Pi per dish (in 4 ml). After stimulation (10
PtdIns(3,4)P2 and PtdIns(3,4,5)P3 accumulation. This mM LPA for 2 min), the media were aspirated and quenched, and
suggests that the expression of the p101/p110g PI3K is [32P]-phospholipids were quantitated as described (Stephens et al.,
critical for the capacity to display this response, that 1991; Hara et al., 1994). In experiments in which HA-PKB activity
was analyzed, transfections contained 2.5 mg each of (myc)-p101Ga subunits are not necessary for this response, and
and (myc)-p120 and 20 mg of either pSG5 HA-PKB or pSG5 HA-that expression of p101/p110g PI3K in a cell could con-
kinase-dead PKB. Assays were conducted with washed HA-directedtribute to the ability of heterotrimeric GTPase activat-
immunoprecipitates, using myelin basic protein as a substrate
ing receptors (e.g., ATP, FMLP, etc.) to stimulate (Burgering and Coffer, 1995).
PtdIns(3,4,5)P3 accumulation. A current classification of
PI3Ks places p85/p110-type PI3Ks (IA) in thesame basic Cloning of the cDNAs Encoding p120 and p101
group as p110g (IB) (Zvelebil et al., 1996). The work We prepared 0.7 mg of total RNA from 4.2 3 109 pig neutrophils
described here further emphasizes the parallels be- (Chomczynski and Sacchi, 1987). This RNA was used by Stratagene
to produce Poly(A)-selected mRNA from which they prepared oli-tween these type IA and IB PI3Ks and, hence, the
go(dT)- and random-primed cDNA libraries in lZAPII (approximatelystrength of this scheme by demonstrating the existence
5.4 3 106 and 3.2 3 106 primary pfu, respectively). Amplified librariesof a p110g-specific adaptor that is necessary for regula-
were constructed from approximately 2 3 106 original recombinants,
tion by Gbgs and hence, cell surface receptors. and these were used to screen for p120 and p101 cDNAs by stan-
PKB is becoming accepted as an effector enzyme dard procedures.
downstream of PI3K (Franke et al., 1995). We have dem- Plaques (2.5 3 106) derived from the oligo(dT)-primed library were
screened with a 32P-labeled oligo based on peptide sequence fromonstrated that p101/p110g PI3K can be regulated by
p120 (CA[T/C] GA[T/C] TT[T/C] ACI CA[A/G] CA[A/G] GTI CA[A/G]cell surface receptors in a manner that allows activation
GTI AT[T/C/A] GA[T/C] ATG). A total of 12 positive clones wereof PKB. This observation is the first evidence showing
identified, isolated as Bluescript-based plasmids, and sequenced.
that an isoform of PI3K that is distinct to p110a or p85/ The inserts of these plasmids represented a series of overlapping
p110 PI3Ks can activate PKB and, taken with the other clones, two of which defined a full-length ORF encoding all of the
results described here, therefore further emphasizes peptide sequence derived from p117/p120 tryptic digests (Fig-
ure 2).that it is the lipid products of PI3Ks that act as their
Plaques (0.9 3 106) derived from the oligo(dT)-primed library wereprimary output signal.
screened using a 32P-labeled oligo based on peptide sequence from
p101 (GGI TA[T/C] ATG GA[A/G] GA[T/C] ATI GA[A/G] GA). One
Experimental Procedures positive clone was identified, isolated, and sequenced. The 59 end
of this clone (D11) represented part of the sequence for the tryptic
Cell Culture peptide from which the probe was designed, thus identifying it as
U937 cells were grown in RPMI 1640 with 10% (v/v) HIFBS (heat- a partial clone. Plaques (3.5 3 106) from the random-primed library
inactivated fetal bovine serum) and diluted 4-fold every 2 days. were then screened using a 32P-labeled, 0.35 kb, N-terminal ApaI
Cos-7 cells were grown in DMEM 10% HIFBS. Sf9 cells were grown restriction fragment derived from D11. A total of 98 positive clones
in TNM FH with 11% HIFBS in a spinner flask (at 278C) and were were identified. These clones were rescreened (at the stage of pri-
maintained at between 0.5 and 2 3 106 cells/ml. mary plaque isolates) by a PCR-based approach, using primers
designed against the Bluescript vector (either ªforwardº orªreverseº
primers) and internal D11 sequence. This enabled us to identifyTransient Expression in Mammalian Cells
Exponentially growing U937 cells (diluted 12 hr previously) were (independent of orientation) the longest potential N-terminal exten-
sions encoding the p101 sequence. The clones giving the largestwashed twice with PBS and resuspended in 0.45ml of sterile electro-
poration medium (EM) containing 30 mM NaCl, 0.12 M KCl, 8.1 mM PCR fragment were isolated and sequenced. These represented
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overlapping clones that, together with D11, defined a full-length AlCl3 (A/F) for 10 min. Assays into which these subunits were diluted
also contained A/F.ORF encoding all of the peptide sequence derived from the p101
tryptic digest (Figure 5).
cDNAs were sequenced by generating a series of nested ExoIII/ Purification of Sf9-Derived Proteins
S1 nuclease deletions or using internal primers for the known se- p120 was purified using a metal-ion chelation column (Talon, Clon-
quences. Both strands of the total cDNAs of p101 and p120 were tech). Cell pellets were thawed and sonicated into 0.1 M NaCl and
independently sequenced. 50 mM sodium phosphate (pH 8.0, 48C); 10 mM Tris±HCl (pH 8.0,
48C), 1 mM MgCl2, and antiproteases (10 mg/ml each of pepstatin
Construction of Expression Vectors A, aprotinin, leupeptin, antipain, and bestatin and 0.1 mM PMSF).
The use of N-terminal PCR and appropriate restriction sites allowed A 120,000 3 g cytosolic fraction was supplemented with Tween 20
the p120 and p101 ORFs to be manipulated into a form in which and betaine (0.05%, w/v, and 1%, respectively) and loaded onto
they could be inserted in-frame into various expression vectors (in Talon resin, which was subsequently washed sequentially with 20
each case, the first amino acid encoded after the N-terminal tag column volumes each of buffers A±D. Buffer (A) contained 50 mM
was the start methionine). The entire 39-untranslated region of the sodium phosphate (pH 8.0, 48C), 10 mM Tris±HCl (pH 8.0, 48C), 0.15
p120 cDNA was used, and that of the p101 cDNA was truncated at M NaCl, 1% betaine, and Tween 20 (0.5%, w/v). Buffer (B) contained
the most N-terminal BamHI site outside the ORF. The vectors used (A) plus Triton X-100 (1%, w/v). Buffer (C) contained (A) but was at
for BV-driven expression in Sf9 cells were pAcHLT (which encodes pH 7.1 and 48C. Buffer (D) contained (A) but was at pH 7.5 and
an N-terminal 63 His tag followed by a thrombin cleavage site contained Tween 20 (0.02%, w/v), ethylene glycol (0.05%, v/v), and
[Pharminogen]; the p120 ORF was insertedusing the XhoI and EcoRI 1 mM MgCl2. The Talon resin was then washed with 8 column vol-
restriction sites) and pAcO-G1 (encodes an N-terminal EE tag [Onyx umes of buffer (E) (which contained [D] supplemented with 10 mM
Pharmaceuticals]; the p101 and p120 ORFs were inserted using the imidazole [pH 7.5]) and buffer F (which contained [D] supplemented
EcoRI and NotI restriction sites). The vectors used for CMV-driven with 70 mM imidazole [pH 7.5, final concentration]. Typically, 1 ml
expression in mammalian cells were pCMV(EE) (encoding an fractions were immediately collected and supplemented with 1 mM
N-terminal MEEEEFMPMEF or MEEEEFMPMEFSS EE tag for p101 DTT and 1 mM EGTA (final concentrations). This yielded 4 mg of
or p120 expression, respectively) and pCMV (myc) (encoding an p120 per liter of Sf9 culture. ªp120 blankº preparations were pre-
N-terminal MEQKLISEEDLEF or MEQKLISEEDLEFSS myc tag for pared from cells infected with wild-type BV.
p101 orp120 expression, respectively). All vectors were N-terminally (EE)-p101 was purified from frozen pellets of Sf9 cells as follows.
sequenced before use. Cells were thawed and sonicated into 0.12 M NaCl, 1 mM MgCl2,
25 mM HEPES (pH 7.4, 48C), and 1 mM EGTA plus antiproteases
(above 2 liters of infected Sf9 culture into 50 ml; all subsequentSf9 Cell Transfections and Production
steps deal with this quantity of lysate), after which the cells wereof Recombinant Proteins
centrifuged (120,000 3 g, 48C, 40 min). Then the supernatant wasSf9 cells were transfected using Insectin (Invitrogen) liposomes with
removed (as described above), supplementedwith Triton X-100 (1%,linearized baculo-gold DNA (Pharminogen) and the relevant BV
w/v), sodium cholate (0.4%), and 0.4 M NaCl (final concentrations),transfer vectors. The resulting RBV were plaque-purified and ampli-
and precleared with 2 ml a-(myc) beads. Next, (EE) proteins werefied. After infection, cells were harvested into ice-cold 0.41% KCl,
collected with 1 ml of a-(EE) beads. After 2 hr of mixing at 48C, the2.66% sucrose, 20 mM MgCl2, and 8 mM NaH2PO4 (pH 6.2, 258C)
beads were washed five times with Triton X-100 (1%, w/v), 0.4%containing 1 mM di-isopropylfluorophosphate. The cells were then
cholate, 0.4 M NaCl, 0.005% SDS, 20 mM HEPES, 1 mM EGTA, andwashed and frozen in liquid N2 and stored at 2808C.
1 mM DTT and three times with buffer (H), comprised of buffer (G)
with Triton X-100 (1%, w/v). Yields of (EE)-p101 were typically onlyPI3K Assays
8%±10% of those of p120. p101 blank (p101C) preparations werePurified aliquots of Sf9-derived or neutrophil-derived PI3K or immu-
from wild-type BV-infected cells. p101/p120 heterodimers formednoprecipitates to be assayed for PI3K activity were diluted in, or
in vivo by coinfection of Sf9 cells with both forms of RBV werewashed into, the last wash buffer, which contained ice-cold 0.12 M
purified as described for (EE)-p101, except that the immunoprecipi-NaCl, 25 mM HEPES, 1 mM EGTA, 1 mM DTT, 1 mg/ml BSA, 1%
tates were washed four times with buffer (I) (which contained Tritonbetaine (0.02%, w/v), and Tween 20 (pH 7.4, 08C). Then 30 ml of a
X-100 [1%, w/v], 0.15 M NaCl; 20 mM HEPES [pH 7.4, 48C], 1 mMmixture of phospholipids with or without Gbgs (see below) and/or
EGTA), twice with buffer (J) (which contained [I] supplemented withGas (either GDP-bound or activated) was added to 5 ml fractions
0.4 M NaCl [final concentration], and then three times with bufferor 10 ml of beads and mixed. After 10 min on ice, 5±10 ml of buffer,
(G) before being eluted with 1 bed volume of 150 mg/ml (EE)-peptidesupplemented with MgCl2 (to give a final concentration of of 3.5
in buffer (G) (final concentration; (EE)-peptide, NH2-T-acetylatedmM), was added and mixed. After 6 min, 5 ml of last wash buffer
EYMPTD, has a very high affinity for the a-(EE) monoclonalantibody;was added (to give a final assay volume of 50 ml) containing [g32P]-
the beads were incubated with (EE)-peptide, on ice, for 40 min, thenATP (typically 10 mCi per assay, Amersham, PB10168) and 3.5 mM
the supernatant was removed). Aliquots of the eluted proteins wereMgCl2. The tubes were then mixed and transferred to a 308C water
diluted and assayed for PI3K activity (see above) or mixed with SDSbath for 15 min. Assays were quenched and extracted, and lipids
sample buffer directly. In in vitro reconstitution experiments, p120were deacylated, resolved on PEI-plates, and quantitated (Stephens
preparations in buffer (G) were supplemented with Triton X-100 (1%,et al., 1994).
w/v; now equivalent to buffer [H]), mixed with (EE)-p101 (10:1 molarPtdIns(4,5)P2 (Stephens et al., 1994) and PtdEtn (Sigma) (final
ratio of protein) still bound to the protein (G) matrix, mixed for 2 hrconcentrations in the assay of 50 mM and 0.5 mM, respectively)
(end on end at 48C), and then washed and eluted with (EE)-peptidewere included; in some experiments, PtdIns4P or PtdIns (Sigma)
as previously described above for the purification of p101/p120-were included.The dried lipid was bath sonicated (at room tempera-
PI3K reconstituted in vivo. (EE)-p120 was purified from Sf9 cells asture) into final wash buffer without BSA and supplemented with
described for (EE)-p101. Yields were typically 1.5±2.0 mg per 5000.1% sodium cholate. Sonicated lipids were mixed with a mixture,
ml of Sf9 culture.totaling 1 ml of per assay, of Gbg storage buffer (1% cholate, 50
mM HEPES [pH 7.5, 48C], 0.1 M NaCl, 1 mM DTT, and 0.5 mM EDTA),
active Gbg, or an equivalent volume of boiled Gbg of 3±7 mg/ml Gbg Binding Assays
Assays (40±80 ml final volume) contained a-(EE)-beads (2 ml packedstocks in storage buffer. In some experiments, the 1 ml included
Ga subunits or their storage buffer, in which case the Gbgs were volume) that had been preincubated with lysates from Sf9 cells
infected with wild-type BV or RBV encoding (EE)-p101 or (EE)-p120premixed with the Ga subunits (either GDP-bound or -activated;
see below) for 10 min on ice. or with the lysis buffer alone. This was arranged such that the beads
carried 1.5±4 mg of p101 or 1.8±4.8 mg of p120. Additional a-(EE)Ga subunits (an equimolar mixture of Ga:o, i1, i2, and i3 prepared
as described [Sternweis and Pang, 1990] and stored in the same beads, preloaded with a lysate from wild-type BV-infected Sf9 cells,
were used to make up the total packed volume of beads in eachbuffer as the Gbg subunits, but supplemented with 10 mM GDP)
were activated by incubation on ice with 10 mM NaF and 30 mM assay to 2 ml. The beads were washed with PBS containing Tween
Gbg-Regulated PI3Ks
113
20 (0.05%, w/v), 1 mM EGTA, and 1 mM DTT. They were then incu- the National Science Foundation (BIR-9420123) and the Irma T.
bated in the same PBS supplemented with 1% BSA (30 mins on Hirschl Trust. The Sloan-Kettering sequencing lab is supported by
ice), washed three more times (in BSA-free buffers), incubated with a National Cancer Institute Core Grant (5 P30 CA08748). P. T. H. is
500 nM Gbg (on ice 45 min, 1:1 molar ratio with p101 or p120), and a BBSRC Research Fellow. A. E. has an EU Fellowship.
finally, washed three times with the above BSA-free buffer before We thank I. Gout and M. Waterfield (Ludwig Institute, Middlesex
adding SDS sample buffer. Branch, London) for ap85 antibodies; B. Burgering, P. Coffer, and
H. Bos (Utrecht University, The Netherlands) for PKB expression
Purification of Pig Neutrophil Gbg-Stimulated vectors; Simon Cook (Onyx Pharmaceuticals) for discussions and
PI3K Activities supplies of (EE)-peptide and a-(EE) and a-(myc) monoclonal anti-
Purifications started with 40±45 g of cytosolic protein (derived from bodies; and other members of the Inositide Laboratory at Babraham
the neutrophils in 750 liters of blood). Two activities (PI3K-A and for their support.
PI3K-B) were completed resolved.
Final preparations of PI3K were incubated with 100 nM [3H]-17- Received May 8, 1996; revised February 20, 1997.
hydroxy-wortmannin (17.7 Ci/mmol; Amersham, custom made), re-
solved by SDS±PAGE, stained with Coomassie, and photographed. References
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